Information sent to healthcare professionals in January 2009 about the safety of medicines

A list of letters sent to healthcare professionals in January 2009, to inform of new safety information and advice.

Date issued
Product
Safety information
16 January 2009 Efavirenz: SUSTIVA and STOCRINPDF file (opens in new window) (339Kb)

SUSTIVA efavirenz 100 mg hard capsule formulation will be discontinued. The following SUSTIVA formulations remain available: 50 mg and 200 mg hard capsules; 600 mg film-coated tablets; 30 mg/mL oral solution

In addition, STOCRIN efavirenz 200 mg film-coated tablets may be available on request from January 2009 for individual patients who meet specific criteria
Week commencing 5 January 2009 Temsirolimus: ToriselPDF file (opens in new window) (66Kb)

Hypersensitivity/infusion reactions (including some life-threatening and rare fatal reactions) have been associated with the administration of temsirolimus (Torisel)

See also Drug Safety Update January 2009, p3

Page last modified: 02 February 2009